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Abstract
Background: Recent studies found that the circulating high-mobility group box 1 (HMGB1) levels could reflect the
disease activity of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). HMGB1 could prime
neutrophils by increasing ANCA antigens translocation for ANCA-mediated respiratory burst and degranulation.
The current study aimed to investigate whether HMGB1 participates in ANCA-induced neutrophil extracellular traps
(NETs) formation, which is one of the most important pathogenic aspects in the development of AAV.
Methods: NETs were induced by treating neutrophils with HMGB1 and ANCA-positive IgG in vitro. NETs formation
was assessed using immunofluorescence microscopy and fluorescence probe. Antagonist for relevant receptors
Toll-like receptor (TLR)2, TLR4 and the receptor for advanced glycation end products (RAGE), as well as NADPH
oxidase molecules were employed.
Results: The percentage of NETs formation was significantly higher in neutrophils stimulated with HMGB1 plus
ANCA-positive IgG than that in neutrophils incubated with HMGB1 or ANCA-positive IgG alone. Consistently,
compared with the nonstimulated neutrophils, the cell-free DNA (cfDNA) concentration of NETs was significantly
increased from 334.09 ± 46.89 ng/ml to 563.32 ± 122.07 ng/ml in the neutrophils incubated with HMGB1 plus
MPO-ANCA-positive IgG (P < 0.001), and from 303.44 ± 37.14 ng/ml to 563.79 ± 145.94 ng/ml in the neutrophils
incubated with HMGB1 plus PR3-ANCA-positive IgG (P < 0.001). The aforementioned effect was significantly
attenuated by antagonist for relevant receptors TLR2, TLR4 and RAGE, as well as blocking NADPH oxidase.
Conclusions: HMGB1 can potentiate ANCA-inducing NETs formation and may be involved in the pathogenesis of
AAV. HMGB1 exerts effects on NETs formation through interaction with TLR2, TLR4 and RAGE, and the process is
NADPH oxidase dependent.
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Background
Antineutrophil cytoplasmic antibody (ANCA)-associated
vasculitis (AAV) encompasses granulomatosis with poly-
angiitis (GPA) and eosinophilic granulomatosis with po-
lyangiitis (EGPA) and microscopic polyangiitis (MPA)
[1]. The serological markers for the aforementioned pri-
mary small vessel vasculitis were ANCAs, which direct
against granule proteins of neutrophils, in particular,
proteinase 3 (PR3) and myeloperoxidase (MPO). Accu-
mulated evidence from in vitro studies, animal models,
and clinical observations suggests that ANCAs play a
critical role in the vascular damage of AAV [2, 3].
Neutrophils are the primary effector cells in the patho-
genesis of AAV [4]. Cytokines or other pro-inflammatory
mediators, such as tumor necrosis factor alpha (TNF-α)
and interleukin (IL)-18, could prime neutrophils by indu-
cing upregulation of the ANCA antigens expression on the
surface of neutrophils. Thus, ANCAs could further activate
primed neutrophils to undergo a respiratory burst and de-
granulation, which plays a crucial role in the development
of vasculitis [5, 6]. Recently, neutrophil extracellular traps
(NETs), generated by ANCA-activated neutrophils, are in-
creasingly recognized as another important aspect in the
pathogenesis of AAV [7, 8]. NETs consist of decondensed
chromatin modification with cytoplasmic proteins such as
MPO and PR3, which are induced by a wide range of stim-
uli including pathogens (bacteria, fungi), activated platelets
and cytokines [8, 9]. NETs can stick to the endothelium
and cause tissue damage during inflammation similar to
neutrophil-induced injury of capillaries in AAV [10]. Recent
studies showed that the abnormal regulation of NETs is in-
volved in the pathogenesis of AAV [7, 11]. On the other
hand, NETs are associated with thrombosis in AAV patients
because histones and DNA within NETs can bind platelets
and blood coagulants [12, 13].
High-mobility group box 1 protein (HMGB1), a ubiqui-
tous nuclear protein involved in nucleosome stabilization
and gene transcription, has potent pro-inflammatory ac-
tions and can be classified as a danger-associated molecu-
lar pattern mediator when placed extracellularly [14].
HMGB1 can interact with Toll-like receptor (TLR)-2,
TLR-4 and the receptor for advanced glycation end prod-
ucts (RAGE) in established cell lines and animal models,
leading to a downstream translocation of nuclear factor
(NF)-κB, inducing pro-inflammatory and chemotactic re-
sponses [15, 16].
Recent studies found that circulating HMGB1 levels are
associated the disease activity and renal involvement of
AAV [17–19], although it remains controversial in some
other studies [20]. Our further study found that HMGB1
could prime neutrophils by increasing ANCA antigens
translocation, and the primed neutrophils could be further
induced by ANCA, resulting in the respiratory burst and
degranulation [21]. Therefore, in the current study, we
hypothesized that HMGB1 can contribute to ANCA-
induced NETs formation. Furthermore, we also investi-
gated receptors and signaling molecules involved in




For immunofluorescence analysis, rabbit polyclonal anti-
Cit-histone H3 antibody and mouse monoclonal anti-
human myeloperoxidase antibody were purchased from
Abcam (Cambridge, UK), Alexa Fluor 488 donkey anti-
rabbit IgG and Cy3-labeled donkey anti-mouse IgG were
purchased from Jackson ImmunoResearch (West Grove,
PA, USA), and 4′,6-diamidino-2-phenylindole (DAPI) was
purchased from Zhongshan Golden Bridge Biotechnology
(Beijing, China). Phorbol myristate acetate (PMA) and
diphenyleneiodonium (DPI) were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Purified anti-human CD282
(TLR2) and CD284 (TLR4) were purchased from BioLe-
gend (San Diego, CA, USA). Recombinant HMGB1 pro-
teins were purchased from R&D Systems (C23 and C45
disulfide C106 thiol form) (Abingdon, UK). RAGE-Fc was
purchased from R&D Systems (Minneapolis, MN, USA).
Preparation of IgG
Normal immunoglobulin G (IgG) and ANCA-positive
IgG were prepared from plasma of normal volunteers
and patients with active PR3-ANCA- or MPO-ANCA-
positive primary small vessel vasculitis. Plasma was
filtered through a 0.22 mm syringe filter (Gelman Sci-
ences, Ann Arbor, MI, USA) and applied to a HiTrap
Protein G column on an AKTA-FPLC system (GE Bio-
sciences, South San Francisco, CA, USA). Preparation of
IgG was performed according to the methods described
previously [22, 23].
Neutrophil isolation
Neutrophils were isolated as described previously
[24]. Briefly speaking, venous human blood for neu-
trophil isolation was obtained from healthy donors by
venipuncture and anticoagulated with EDTA. Neutrophils
were isolated by density gradient centrifugation on
Lymphoprep (Nycomed, Oslo, Norway). Erythrocytes
were lysed with ice-cold ammonium chloride buffer, and
neutrophils were washed with phosphate-buffered saline
(PBS) (Beijing Chemical Reagents, Beijing, China). The
purity of the neutrophils was above 95 %. Neutrophils
were then suspended in RPMI 1640 containing 0.5 %
heat-inactivated fetal bovine serum (FBS). We obtained
written informed consent from all participants. The re-
search was in compliance of the Declaration of Helsinki
and approved by the ethics committee of the Peking
University First Hospital.
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NETs induction
NETs induction was according to the protocols described
previously, with some minor modifications [25, 26].
Isolated neutrophils were seeded on 13 mm glass cover-
slips in 24-well plates in 400 μl of RPMI 1640 supple-
mented with 0.5 % heat-inactivated FBS at a density of
1 × 105 cells per well. The plates were incubated for 30–
60 min at 37 °C to allow adhesion of the cells. Then
neutrophils were incubated with the buffer control or
HMGB1 at a concentration of 10 ng/ml, which was com-
parable to the circulating HMGB1 level in active AAV pa-
tients, as demonstrated in our previous study [18], for
30 min at 37 °C. Then we stimulated the pretreated neu-
trophils with a concentration of patient-derived ANCA-
positive IgG at 300 μg/ml in an incubator containing 5 %
CO2 at 37 °C for 3 h. In order to investigate the role of
candidate receptors through which HMGB1 exerted its ef-
fect, neutrophils were first incubated with blocking anti-
bodies (anti-TLR2 at 10 μg/ml; anti-TLR4 at 10 μg/ml;
RAGE-Fc at 1 μg/ml) for 30 min on ice. The above time
set and inhibiting concentrations were according to our
previous study [21]. We used phorbol myristate acetate
(PMA) at a concentration of 100 nM in an incubator con-
taining 5 % CO2 at 37 °C for 3.5 h as the positive control.
Then we fixed the cells with 4 % paraformaldehyde (PFA)
for further immunocellular chemistry (ICC).
NETs immunofluorescence
We detected NETs by immunolabeling as described pre-
viously [26]. Coverslips with the fixed cells were re-
moved from the plates and processed by floating on
drops kept on a parafilm sheet covering a test tube
stand. The samples were permeabilized for 1 min with
0.5 % Triton X-100 after washing with PBS, washed
again with PBS. Unspecific binding sites were blocked in
PBS containing 5 % donkey serum. The samples were
then incubated for 60 min respectively with the primary
antibody as follows: anti-human myeloperoxidase mouse
monoclonal antibody (diluted 1:100) and anti-human
Cit-H3 rabbit polyclonal antibody (diluted 1:100). After
washing with PBS, each primary antibody was visualized
using secondary antibodies coupled to AF488-labeled
donkey anti-rabbit IgG and Cy3-labeled donkey anti-
mouse IgG (both 1:400, Jackson ImmunoResearch, West
Grove, PA, USA) were applied for 60 min. The primary
and secondary antibodies were diluted with PBS. After
incubation for 60 min with the secondary antibodies, the
specimens were washed with PBS, and the DNA was
stained with DAPI for 5 min. All procedures were per-
formed at room temperature. In negative controls, pri-
mary antibodies were replaced by PBS. Confocal images
were captured with a Zeiss LSM 780 confocal micro-
scope (Zeiss, Jena, Germany). Five images taken ran-
domly from different regions of each coverslip in the
experiment were taken with the 10× lens on a fluores-
cence microscope [25]. Exposure times of each channel
were kept constant over the whole series in the experi-
ment after calibrating on a bright representative sample
to avoid saturated pixels. The image files were analyzed
with the Image-Pro Plus 6.0 software (Media Cybernet-
ics, Silver Spring, MD, USA). The NET percentage was
calculated as follows: NET rate [%] = 100 × number of
neutrophils displaying expanded nuclei and releasing
DNA fibers/total number of neutrophils.
Quantification of DNA release from neutrophils
NETs formation was quantified using PicoGreen as de-
scribed previously [27]. Lambda DNA of known concen-
tration was serially diluted with Tris-EDTA (TE) buffer
(10 mM Tris-HCl, 1 mM EDTA, pH 7.5) to create
standard DNA samples. To follow NETs formation,
100 μl fresh neutrophils (1 × 105cells) were seeded in
Costar 96-well black plates (Corning, Tewksbury, MA,
USA) in the presence of 0.5 % FBS. Neutrophils were
pretreated with buffer or 10 ng/ml HMGB1 for 30 min
followed by stimulation with MPO-ANCA-positive IgG,
or PR3-ANCA-positive IgG, or normal IgGs in an incu-
bator containing 5 % CO2 at 37 °C for 3 h, respectively.
For assay of the role of candidate receptors, certain
groups of neutrophils were preincubated with relevant
reagents for 30 min on ice before being pretreated with
HMGB1. Some 100 μl of the PicoGreen dye diluted
1:200 in TE buffer was added to the microplate in order
to make a final volume of 200 μl per well. Following in-
cubation in the dark for 5 min at room temperature, the
fluorescent signal of the sample was measured using the
microplate fluorescence reader (TriStar Multimode
Microplate Reader LB941, Berthold Technologies, Bad
Wildbad, Germany), at an excitation wavelength of
480 nm and an emission wavelength of 530 nm.
Statistical analysis
Differences between the two sets of data were analyzed
using t tests. When the differences between more than two
sets of data were analyzed, we used the one-way analysis of
variance. A P value < 0.05 was considered to be statistically
significant. Reported values were expressed as mean ±
standard deviation (SD). Analyses were performed on SPSS
version 13.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Neutrophils pretreated with HMGB1 showed greater
ability to produce NETs in the presence of ANCA
We investigated the effects of HMGB1 on ANCA-
induced NETs formation. ANCA-IgG were prepared
from two patients with active PR3-ANCA-positive vas-
culitis, five patients with active MPO-ANCA-positive
vasculitis and three healthy volunteers, respectively.
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Neutrophils of the abovementioned nine healthy donors
were analyzed. The NETs were quantified by measuring
cell-free DNA (cfDNA) concentration with the Quant-iT
PicoGreen fluorescence probe. Compared with the buffer
control, the cell-free DNA concentration increased sig-
nificantly in neutrophils incubated with HMGB1 plus
MPO-ANCA-positive IgG or PR3-ANCA-positive IgG
(334.09 ± 46.89 vs. 563.32 ± 122.07, P < 0.001; 303.44 ±
37.14 vs. 563.79 ± 145.94, P < 0.001, respectively). Com-
pared with neutrophils incubated with HMGB1 or ANCA-
positive IgG alone, the cell-free DNA concentration of
NETs increased significantly from 337.29 ± 99.06 ng/ml and
430.05 ± 43.79 ng/ml to 563.32 ± 122.07 ng/ml in the
neutrophils incubated with HMGB1 plus MPO-ANCA-
positive IgG (P < 0.001, P = 0.017, respectively), from
359.82 ± 76.86 ng/ml and 407.25 ± 89.90 ng/ml to
563.79 ± 145.94 ng/ml in the neutrophils incubated with
HMGB1 plus PR3-ANCA-positive IgG (P = 0.002, P =
0.018, respectively) (Fig. 1). No obvious NET formation
was observed with HMGB1, ANCA-IgG alone, normal
IgG alone or HMGB1 plus normal IgG, either. PMA was
used as a positive control.
We further measured the percentage of NETs forma-
tion by immunofluorescence. The typical NETs was
composed of extracellular DNA and colocalization of
histone, granular proteins MPO (Fig. 2). Consistently,
for MPO-ANCA-positive IgG, the percentage of NETs
formation was 14.41 ± 2.48 % in the neutrophils incu-
bated with HMGB1 plus MPO-ANCA-positive IgG,
which was significantly higher than neutrophils
Fig. 1 Neutrophils pretreated with HMGB1 showed greater ability to produce NETs in the presence of ANCA-positive IgG. NETs induced by MPO-ANCA-
positive IgG (a) or PR3-ANCA-positive IgG (b) were measured by cell-free DNA concentration in HMGB1-pretreated neutrophils. c and d were representative
histograms showing that the percentage of NETs formation induced by MPO-ANCA-positive IgG and PR3-ANCA-positive IgG in HMGB1-pretreated
neutrophils. Bars represent mean ± SD of repeated measurements on neutrophils of 9–12 independent experiments and 9 donors. ANCA antineutrophil
cytoplasmic antibody, HMGB1 high-mobility group box 1, IgG immunoglobulin G, MPO myeloperoxidase, NETs neutrophil extracellular traps, PR3 pro-
teinase 3, PMA phorbol myristate acetate
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Fig. 2 HMGB1 plus ANCA-positive-IgG induces NETs formation in vitro. Human neutrophils were activated in vitro and then processed for
immunofluorescence. a Representative images show neutrophil DNA (blue). b Representative images show immunostained with anti-human myelo-
peroxidase antibodies against myeloperoxidase (red). c Representative images show immunostained with anti-Cit-histone H3 antibodies against the his-
tone H3 complex (green). d Representative images show merged neutrophil DNA (blue), histone H3 (green) and myeloperoxidase (red) staining. ANCA
antineutrophil cytoplasmic antibody, HMGB1 high-mobility group box 1, IgG immunoglobulin G, NETs neutrophil extracellular traps
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incubated with HMGB1 alone or MPO-ANCA-positive
IgG alone (6.16 ± 1.52 % vs. 14.41 ± 2.48 %, P = 0.001;
6.80 ± 1.21 % vs. 14.41 ± 2.48 %, P = 0.001, respectively).
For PR3-ANCA-positive IgG, the percentage of NETs
formation was 14.99 ± 6.55 % in the neutrophils incu-
bated with HMGB1 plus PR3-ANCA-positive IgG, which
was significantly higher than neutrophils incubated with
HMGB1 alone or PR3-ANCA-positive IgG alone (8.82 ±
2.66 % vs. 14.99 ± 6.55 %, P = 0.024; 8.04 ± 2.33 % vs.
14.99 ± 6.55 %, P = 0.012, respectively) (Fig. 1). There
was no significant difference between neutrophils incu-
bated with ANCA-positive IgG alone and HMGB1
alone. As the positive control, 49.33 ± 4.42 % of neutro-
phils incubated with PMA produced NETs.
The effects of HMGB1 and ANCA on NETs formation were
dose dependent
Neutrophils were pretreated with various concentrations
of HMGB1 (0, 1, 2, 5, 10, 100 and 1000 ng/ml, respect-
ively), then were stimulated with ANCA-positive IgG at
a concentration of 300 μg/ml. The results showed that
the effect of HMGB1 potentiating ANCA-inducing
NETs formation was dose dependent (Fig. 3a).
On the other hand, neutrophils were pretreated with
the same concentrations of HMGB1 (10 ng/ml), then
were stimulated by various concentration of ANCA-
positive IgG (0, 50, 100, 300, 500, and 700 μg/ml, respect-
ively). The results showed that the effects of PR3- and
MPO-ANCA-positive IgG-inducing NETs formation were
both dose dependent (Fig. 3b and c).
HMGB1-dependent engagement of TLR2, TLR4 and RAGE
contributed to NETs formation in the presence of ANCA
Since HMGB1 contributes to NETs formation in the
presence of ANCA-positive IgG, we next investigated
whether TLR2, TLR4 and RAGE were required in the
process of HMGB1 promoting ANCA-induced NETs
formation. Certain groups of neutrophils were pretreated
with blocking relevant antibodies before the incubating
with HMGB1. In neutrophils incubated with HMGB1
plus MPO-ANCA-positive IgG, the cell-free DNA con-
centration was 537.25 ± 90.11 ng/ml, which decreased to
403.51 ± 87.89 ng/ml upon preincubating with anti-
TLR2 antibody (P = 0.012), or 386.18 ± 79.14 ng/ml upon
preincubating with anti-TLR4 antibody (P = 0.003), or
340.62 ± 66.44 ng/ml by preincubating with RAGE an-
tagonist (P < 0.001), or 371.89 ± 70.22 ng/ml by preincu-
bating with the three blocking antibodies and inhibitors
combined (P = 0.001). For PR3-ANCA-positive IgG, the
cell-free DNA concentration was 540.33 ± 142.82 ng/ml,
which was decreased to 355.79 ± 64.70 ng/ml upon prein-
cubating with anti-TLR2 antibody (P = 0.005), or 367.42 ±
73.51 ng/ml upon preincubating with anti-TLR4 antibody
(P = 0.009), or 371.46 ± 56.36 ng/ml by preincubating with
RAGE antagonist (P = 0.008), or 355.24 ± 51.29 ng/ml by
preincubating with the three blocking antibodies and in-
hibitors combined (P = 0.008) (Fig. 4).
We further measured the percentage of NETs forma-
tion by immunofluorescence. Consistently, in neutro-
phils incubated with HMGB1 plus MPO-ANCA-positive
IgG, the percentage of NET formation decreased from
14.56 ± 1.42 % to 8.87 ± 1.75 % upon preincubating with
anti-TLR2 antibody (P = 0.002), or 8.51 ± 2.06 % upon
preincubating with anti-TLR4 antibody (P = 0.001), or
8.16 ± 2.03 % by preincubating with RAGE antagonist
(P < 0.001), or 8.59 ± 1.43 % by preincubating with the
three blocking antibodies and inhibitors combined (P =
0.001). For PR3-ANCA-positive IgG, the percentage of
NETs formation decreased from 13.91 ± 2.61 % to 8.78 ±
0.44 % upon preincubating with anti-TLR2 antibody (P =
0.004), or 8.81 ± 1.72 % upon preincubating with anti-
TLR4 antibody (P = 0.005), or 8.78 ± 1.42 % by
Fig. 3 Dose–response curve of HMGB1 and ANCA-positive IgG on NETs information. a Dose–response curve for HMGB1 on potentiating ANCA-
inducing NETs formation. b Dose–response curve for MPO-ANCA-positive IgG-inducing NETs formation. c Dose–response curve for PR3-ANCA-
positive IgG-inducing NETs formation. Bars represent mean of repeated measurements on neutrophils of 4 independent experiments. ANCA
antineutrophil cytoplasmic antibody, HMGB1 high-mobility group box 1, IgG immunoglobulin G, MPO myeloperoxidase, NETs neutrophil
extracellular traps, PR3 proteinase 3
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preincubating with RAGE antagonist (P = 0.004), or 9.05
± 2.43 % by preincubating with the three blocking anti-
bodies and inhibitors combined (P = 0.006) (Fig. 4).
To further confirm the receptors through which
HMGB1 exerts its effects, we used TLR2−/− and TLR4
−/− mice [28]. However, RAGE−/− mice are not com-
mercially available. These results were in line with our
data of human neutrophils with inhibitors and blocking
antibodies to block the activity of corresponding recep-
tors. For detailed information, see Additional file 1.
As shown in Figure S1 in Additional file 2, compared with
nonstimulated murine neutrophils, the percentage of NETs
formation was significantly higher in neutrophils from B6
or B10 wild-type mice stimulated with HMGB1 plus anti-
MPO IgGs (25.89 ± 1.67 % vs. 29.95 ± 2.10 %, P = 0.020;
13.83 ± 2.15 % vs. 19.70 ± 1.45 %, P < 0.001, respectively),
but there were no significant differences in the percentage
of NETs formation in neutrophils from TLR2−/− mice or
TLR4−/− mice, between nonstimulated murine neutrophils
and neutrophils stimulated by HMGB1 plus anti-MPO IgGs
(26.97 ± 0.76 % vs. 26.69 ± 1.80 %, P = 0.930; 11.93 ± 1.48 %
vs. 10.80 ± 1.91 %, P= 0.645, respectively).
Collectively, these results indicated that TLR2, TLR4
and RAGE were required in the process of HMGB1 pro-
moting NETs formation in the presence of ANCA-
positive IgG.
NET formation was dependent on NADPH oxidase in the
presence of HMGB1 and ANCA-positive IgG
Recent studies demonstrated that NETosis can occur in
a reactive oxygen species (ROS)-independent manner,
such as Candida albicans and uric acid-inducing NETs
formation [29, 30]. In addition, a study by Tadie et al.
showed that HMGB1 induced NETs formation also inde-
pendent of NADPH oxidase ROS production [28]. Our
study showed that neutrophils incubated with HMGB1
Fig. 4 HMGB1-dependent engagement of TLR2, TLR4 and RAGE contributed to NETs formation in the presence of ANCA-positive IgG. Blockage of
TLR2, TLR4 and RAGE decreased DNA release by MPO-ANCA-positive IgG (a) or PR3-ANCA-positive IgG (b) in HMGB1-pretreated cells. Blockage of
TLR2, TLR4 and RAGE decreased percentage of NETs formation by MPO-ANCA-positive IgG (c) or PR3-ANCA-positive IgG (d) in HMGB1-pretreated
cells. Bars represent mean ± SD of repeated measurements on neutrophils of 8–9 independent experiments and 9 donors. ANCA antineutrophil
cytoplasmic antibody, HMGB1 high-mobility group box 1, IgG immunoglobulin G, MPO myeloperoxidase, NETs neutrophil extracellular traps, PR3
proteinase 3, RAGE receptor for advanced glycation end products, TLR Toll-like receptor
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plus MPO-ANCA-positive IgG or PR3-ANCA-positive
IgG, the cell-free DNA concentration decreased from
553.66 ± 118.10 ng/ml and 577.93 ± 121.69 ng/ml to
458.33 ± 136.59 ng/ml and 450.93 ± 107.54 ng/ml, re-
spectively, by preincubating with DPI (P = 0.010 and P =
0.001, respectively) (Fig. 5). Consistently, in neutrophils
incubated with HMGB1 plus MPO-ANCA-positive IgG
or PR3-ANCA-positive IgG, the percentage of NET for-
mation was decreased from 14.41 ± 2.48 % and 14.99 ±
6.55 % to 7.42 ± 0.51 % and 7.09 ± 2.57 %, respectively,
by preincubating with DPI (P = 0.003 and P = 0.005, re-
spectively) (Fig. 5). These results suggested that NETs
formation in neutrophils incubated with HMGB1 plus
ANCA was also dependent on NADPH oxidase ROS
production.
Discussion
In the study by Tadie et al., it was shown that HMGB1
alone contributes to NETs formation in vitro or under
relevant in vivo conditions, but the concentrations of
HMGB1 was 300 ng/ml in their study, which is much
higher than the pathophysiological concentration of circu-
lating HMGB1 in active AAV patients [28]. In the current
study, we demonstrated that 10 ng/ml HMGB1 can con-
tribute to ANCA-induced NETs formation. Our previous
study found that HMGB1 could prime neutrophils, and
further result in the respiratory burst and degranulation in
the presence of ANCA [21]. The findings of the current
study extended the role of HMGB1 in activating neutro-
phils, and thus, may contribute to the development of
AAV. Although the concentration of HMGB1 used in our
study was comparable to the circulating HMGB1 level in
active AAV patients [18], we cannot exclude that local
concentrations of HMGB1 may be higher.
Extracellular HMGB1 induces several responses, in-
cluding the release of pro-inflammatory cytokines, cell
proliferation and cell migration [31, 32]. Several recep-
tors have been implicated in HMGB1-mediated func-
tions, including RAGE and TLR2 and TLR4 [33–36]. It
is not fully clear which of these receptors are required
Fig. 5 NETs formation was dependent on NADPH oxidase in the presence of HMGB1 and ANCA-positive IgG. Blockage of NADPH oxidase
decreased DNA release by MPO-ANCA-positive IgG (a) or PR3-ANCA-positive IgG (b) in HMGB1-pretreated cells. Blockage of NADPH oxidase
decreased percentage of NETs formation by MPO-ANCA-positive IgG (c) or PR3-ANCA-positive IgG (d) in HMGB1-pretreated cells. Bars represent
mean ± SD of repeated measurements on neutrophils of 13–14 independent experiments and 9 donors. ANCA antineutrophil cytoplasmic
antibody, DPI diphenyleneiodonium, HMGB1 high-mobility group box 1, IgG immunoglobulin G, MPO myeloperoxidase, NETs neutrophil
extracellular traps, PR3 proteinase 3
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for the different bio-function of HMGB1. The current
study showed that HMGB1-dependent engagement of
TLR2, TLR4 and RAGE contributed to ANCA-induced
NETs formation. Our previous study found that HMGB1
exerts priming effects on neutrophils by increasing
ANCA antigens translocation, which was TLR4 and
RAGE dependent, not TLR2 dependent [21], while
Tadie’s study showed that the NETs formation induced
by HMGB1 alone was TLR4 dependent, not TLR2 or
RAGE dependent [28]. Thus, the process of HMGB1 po-
tentiating ANCA-induced NETs formation may be dis-
tinct from facilitating neutrophil respiratory burst and
directly inducing NETs formation.
The mechanisms responsible for NETs formation is
not completely delineated yet. Despite that previous
studies showed that NETs formation requires activation
of NADPH oxidase and production of ROS [37], there is
now growing evidence suggesting that some stimuli in-
duce NETs formation independent of NADPH oxidase
[30]. Indeed, the study by Tadie et al. showed that
HMGB1-inducing NETs formation was independent of
ROS generated by NADPH oxidase [28], which is
consistent with rapid NETs formation in response to
Candida albicans and uric acid-inducing NETs forma-
tion [29, 30]. However, our results indicated that the
HMGB1 plus ANCA-IgG-inducing NETs formation was
dependent on ROS generation. These findings suggested
that HMGB1 contributing to NETs formation may in-
volve heterogeneous mechanisms in the context of the
dependency on NADPH oxidase and production of ROS.
Conclusions
Our study demonstrated that HMGB1 can potentiate
ANCA-inducing NETs formation. HMGB1 exerts effects
on NETs formation through the interaction with TLR2,
TLR4 and RAGE, and the process is NADPH oxidase
dependent. Blockade of HMGB1 might limit inflamma-
tory damage caused by ANCA-induced NETs formation.
Additional files
Additional file 1: Materials and methods. (PDF 194 kb)
Additional file 2: Figure S1. Anti-MPO IgGs-induced NETs formation in
HMGB1-pretreated murine neutrophils from TLR2–/– and TLR4–/– mice.
NETs formation was measured by Sytox Green staining. The percentage
of Sytox-positive cells did not increase in neutrophils from TLR2–/– mice
(A) and TLR4–/– mice (B) as wild-type mice, respectively. Bars represent
mean ± SD of repeated measurements on neutrophils of 3–6 independent
experiments and mice. (TIF 11111 kb)
Abbreviations
AAV: ANCA-associated vasculitis; ANCA: Antineutrophil cytoplasmic antibody;
EGPA: Eosinophilic granulomatosis with polyangiitis; FBS: Fetal bovine serum;
GPA: Granulomatosis with polyangiitis; HMGB1: High-mobility group box 1;
IgG: Immunoglobulin G; IL: Interleukin; MPA: Microscopic polyangiitis;
MPO: Myeloperoxidase; NETs: Neutrophil extracellular traps; NF-κB: Nuclear
factor kappa B; PBS: Phosphate-buffered saline; PR3: Proteinase 3;
RAGE: Receptor for advanced glycation end products; ROS: reactive oxygen
species; TLR: Toll-like receptor; TNF-α: Tumor necrosis factor alpha.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YHM carried out the experiments, analyzed the data and drafted the
manuscript. TTM contributed methods of immunofluorescence and helped
to revise the manuscript. CW participated in the design of the study and
helped to revise the manuscript. HW and DYC contributed reagents/
materials/analysis tools and helped to revise the manuscript. MHZ conceived
of the study, participated in its design and coordination and helped to draft
the manuscript. MC conceived of the study, participated in its design and
coordination, helped to draft the manuscript and he is responsible for the
interpretation of the data. All authors read and approved the final
manuscript.
Acknowledgements
This study is supported by a grant from the Chinese 973 Project (No.
2012CB517702), and three grants from the National Natural Science Fund
(No. 81425008, No. 81321064 and No. 81300599), and the National Key
Technology Research and Development (R&D) Program of the Ministry of
Science and Technology of China (No. 2011BAI10B04).
Author details
1Renal Division, Department of Medicine, Peking University First Hospital,
Peking University Institute of Nephrology, Beijing 100034, China. 2Key
Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034,
China. 3Key Laboratory of Chronic Kidney Disease Prevention and Treatment,
Peking University, Ministry of Education, Beijing 100034, China.
4Peking-Tsinghua Center for Life Sciences, Beijing 100034, China. 5Renal
Division, Department of Medicine, First Affiliated Hospital of Guangxi Medical
University, Nanning, Guangxi Zhuang Autonomous Region 530021, China.
Received: 18 September 2015 Accepted: 18 December 2015
References
1. Kallenberg CG. Key advances in the clinical approach to ANCA-associated
vasculitis. Nat Rev Rheumatol. 2014;10:484–93.
2. Bosch X. LAMPs and NETs in the pathogenesis of ANCA vasculitis. J Am Soc
Nephrol. 2009;20:1654–6.
3. Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic
autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10:463–73.
4. Schreiber A, Choi M. The role of neutrophils in causing antineutrophil
cytoplasmic autoantibody-associated vasculitis. Curr Opin Hematol. 2015;22:60–6.
5. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic
autoantibodies induce neutrophils to degranulate and produce oxygen
radicals in vitro. Proc Natl Acad Sci U S A. 1990;87:4115–9.
6. Savage CO. Pathogenesis of anti-neutrophil cytoplasmic autoantibody
(ANCA)-associated vasculitis. Clin Exp Immunol. 2011;164 Suppl 1:23–6.
7. Nakazawa D, Shida H, Tomaru U, Yoshida M, Nishio S, Atsumi T, et al.
Enhanced formation and disordered regulation of NETs in myeloperoxidase-
ANCA-associated microscopic polyangiitis. J Am Soc Nephrol. 2014;25:990–7.
8. Yipp BG, Kubes P. NETosis: how vital is it? Blood. 2013;122:2784–94.
9. Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is
a silent process. J Immunol. 2013;191:2647–56.
10. Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z,
et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med.
2009;15:623–5.
11. Ray K. Autoimmunity: disordered NETs implicated in pathogenesis of
MPO-ANCA-associated vasculitis. Nat Rev Rheumatol. 2012;8:501.
12. Nakazawa D, Tomaru U, Yamamoto C, Jodo S, Ishizu A. Abundant
neutrophil extracellular traps in thrombus of patient with microscopic
polyangiitis. Front Immunol. 2012;3:333.
13. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers Jr DD, et al.
Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A.
2010;107:15880–5.
Ma et al. Arthritis Research & Therapy  (2016) 18:2 Page 9 of 10
14. Yang H, Antoine DJ, Andersson U, Tracey KJ. The many faces of HMGB1:
molecular structure-functional activity in inflammation, apoptosis, and
chemotaxis. J Leukoc Biol. 2013;93:865–73.
15. Schaper F, Westra J, Bijl M. Recent developments in the role of high-mobility
group box 1 in systemic lupus erythematosus. Mol Med. 2014;20:72–9.
16. Wagner M. A dangerous duo in adipose tissue: high-mobility group box 1
protein and macrophages. Yale J Biol Med. 2014;87:127–33.
17. Bruchfeld A, Wendt M, Bratt J, Qureshi AR, Chavan S, Tracey KJ, et al. High-
mobility group box-1 protein (HMGB1) is increased in antineutrophilic
cytoplasmatic antibody (ANCA)-associated vasculitis with renal
manifestations. Mol Med. 2011;17:29–35.
18. Wang C, Gou SJ, Chang DY, Yu F, Zhao MH, Chen M. Association of
circulating level of high mobility group box 1 with disease activity in
antineutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis Care
Res (Hoboken). 2013;65:1828–34.
19. Henes FO, Chen Y, Bley TA, Fabel M, Both M, Herrmann K, et al. Correlation
of serum level of high mobility group box 1 with the burden of
granulomatous inflammation in granulomatosis with polyangiitis
(Wegener’s). Ann Rheum Dis. 2011;70:1926–9.
20. de Souza A, Westra J, Bijzet J, Limburg PC, Stegeman CA, Bijl M, et al. Is
serum HMGB1 a biomarker in ANCA-associated vasculitis? Arthritis Res Ther.
2013;15:R104.
21. Wang C, Wang H, Chang DY, Hao J, Zhao MH, Chen M. High mobility group
box 1 contributes to anti-neutrophil cytoplasmic antibody-induced
neutrophils activation through receptor for advanced glycation end
products (RAGE) and Toll-like receptor 4. Arthritis Res Ther. 2015;17:64.
22. Choi M, Rolle S, Rane M, Haller H, Luft FC, Kettritz R. Extracellular signal-
regulated kinase inhibition by statins inhibits neutrophil activation by ANCA.
Kidney Int. 2003;63:96–106.
23. Schreiber A, Rolle S, Peripelittchenko L, Rademann J, Schneider W, Luft FC,
et al. Phosphoinositol 3-kinase-gamma mediates antineutrophil cytoplasmic
autoantibody-induced glomerulonephritis. Kidney Int. 2010;77:118–28.
24. Hao J, Huang YM, Zhao MH, Chen M. The interaction between C5a and
sphingosine-1-phosphate in neutrophils for antineutrophil cytoplasmic
antibody mediated activation. Arthritis Res Ther. 2014;16:R142.
25. Brinkmann V, Goosmann C, Kühn LI, Zychlinsky A. Automatic quantification
of in vitro NET formation. Front Immunol. 2012;3:413.
26. Brinkmann V, Laube B, Abu Abed U, Goosmann C, Zychlinsky A. Neutrophil
Extracellular traps: how to generate and visualize them. J Vis Exp. 2010:24;
e1724.
27. Zhang S, Lu X, Shu X, Tian X, Yang H, Yang W, et al. Elevated plasma cfDNA
may be associated with active lupus nephritis and partially attributed to
abnormal regulation of neutrophil extracellular traps (NETs) in patients with
systemic lupus erythematosus. Inter Med. 2014;53:2763–71.
28. Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, et al. HMGB1 promotes
neutrophil extracellular trap formation through interactions with Toll-like
receptor 4. Am J Physiol Lung Cell Mol Physiol. 2013;304:L342–9.
29. Arai Y, Nishinaka Y, Arai T, Morita M, Mizugishi K, Adachi S, et al. Uric acid
induces NADPH oxidase-independent neutrophil extracellular trap
formation. Biochem Biophys Res Commun. 2014;443:556–61.
30. Byrd AS, O'Brien XM, Johnson CM, Lavigne LM, Reichner JS. An extracellular
matrix-based mechanism of rapid neutrophil extracellular trap formation in
response to Candida albicans. J Immunol. 2013;190:4136–48.
31. Charoensup J, Sermswan RW, Paeyao A, Promakhejohn S, Punasee S,
Chularari C, et al. High HMGB1 level is associated with poor outcome of
septicemic melioidosis. Int J Infect Dis. 2014;28:111–6.
32. Feng XJ, Liu SX, Wu C, Kang PP, Liu QJ, Hao J, et al. The PTEN/PI3K/Akt
signaling pathway mediates HMGB1-induced cell proliferation by regulating
the NF-kappaB/cyclin D1 pathway in mouse mesangial cells. Am J Physiol
Cell Physiol. 2014;306:C1119–28.
33. Qin Y, Chen Y, Wang W, Wang Z, Tang G, Zhang P, et al. HMGB1-LPS
complex promotes transformation of osteoarthritis synovial fibroblasts to
a rheumatoid arthritis synovial fibroblast-like phenotype. Cell Death Dis.
2014;5:e1077.
34. Park SY, Lee SW, Kim HY, Lee WS, Hong KW, Kim CD. HMGB1 induces
angiogenesis in rheumatoid arthritis via HIF-1alpha activation. Eur J Immunol.
2015;45:1216–27.
35. Lin Q, Yang XP, Fang D, Ren X, Zhou H, Fang J, et al. High-mobility group
box-1 mediates toll-like receptor 4-dependent angiogenesis. Arterioscler
Thromb Vasc Biol. 2011;31:1024–32.
36. Kang R, Zhang Q, Zeh 3rd HJ, Lotze MT, Tang D. HMGB1 in cancer: good,
bad, or both? Clin Cancer Res. 2013;19:4046–57.
37. Zawrotniak M, Rapala-Kozik M. Neutrophil extracellular traps (NETs) -
formation and implications. Acta Biochim Pol. 2013;60:277–84.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Ma et al. Arthritis Research & Therapy  (2016) 18:2 Page 10 of 10
